FBXO22 is involved in cell development and differentiation, including in cancer, by controlling the stability of lysine demethylase 4A (KDM4A) (3); FBXO22 ubiquitylates p53 and forms a complex with KDM4A to regulate cellular senescence (4). The gene discussed is KDM4A; the disease is cancer.